Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

NCT05415241 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Close Contact Transmission

Interventions

DRUG: FB2001

Sponsor

Ruijin Hospital

Collaborators

[object Object]
[object Object]